Pharmascience, Redx Pharma deal

Pharmascience granted Redx rights to develop and commercialize Pharmascience's small molecule inhibitors of colony-stimulating factor 1 receptor ( CSF1R; C-FMS; CD115) to treat cancer. The program i...